Both in Pharmaceuticals
Aquestive Therapeutics vs Crescent Biopharma
Over the past year AQST returned −40.1% and CBIO returned +9.1%; their daily moves had a correlation of 0.21.
AQST −40.1% CBIO +9.1%Growth of $1, one year, split-adjusted
| Metric | AQST | CBIO |
|---|---|---|
| Price | $3.89 | $13.48 |
| Market cap | $488.2M | $500.7M |
| Today | −3.71% | −4.19% |
| 1 month | −12.4% | −5.5% |
| 6 months | −7.4% | −25.4% |
| Year to date | −39.8% | +13.7% |
| 1 year | −40.0% | +7.8% |
| Revenue growth (YoY) | +38.1% | — |
| Gross margin | 70.9% | — |
| Net margin | −165.5% | — |
| P/E (TTM) | — | — |
| Price / sales | 9.0× | 42.1× |
| Net cash | $47.8M | $171.6M |
| Dividend yield | — | — |
| Volatility (60d) | 56.5% | 68.9% |
| Short % of float | 25.6% | 21.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).